title: Alcohol-induced exacerbation of ischemic brain injury: role of NAD(P)H oxidase.
abstract: BACKGROUND
  Chronic alcohol consumption increases ischemic stroke and exacerbates ischemic brain injury. We determined the role of NAD(P)H oxidase in exacerbated ischemic brain injury during chronic alcohol consumption.
  
  
  METHODS
  Sprague Dawley rats were fed a liquid diet with or without alcohol (6.4% v/v) for 8 weeks. We measured the effect of apocynin on 2-hour middle cerebral artery occlusion (MCAO)/24-hour reperfusion-induced brain injury. In addition, superoxide production and expression of NAD(P)H oxidase subunit, gp91phox, in the peri-infarct area were assessed.
  
  
  RESULTS
  Chronic alcohol consumption produced a larger infarct volume, worse neurological score, and higher superoxide production. Acute (5 mg/kg, ip, 30 minutes before MCAO) and chronic treatment with apocynin (7.5 mg/kg/d in the diet, 4 weeks prior to MCAO) reduced infarct volume, improved neurological outcome, and attenuated superoxide production in alcohol-fed rats. Expression of gp91phox at basal conditions and following ischemia/reperfusion was greater in alcohol-fed rats compared to non-alcohol-fed rats. In addition, neurons are partially responsible for upregulated gp91phox during alcohol consumption.
  
  
  CONCLUSIONS
  Our findings suggest that NAD(P)H oxidase may play an important role in exacerbated ischemic brain injury during chronic alcohol consumption.
authors.affiliation: Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, Nebraska 68198-5850, USA.
authors.forename: Honggang
authors.initials: H
authors.lastname: Zhao
authors.forename: William G
authors.initials: WG
authors.lastname: Mayhan
authors.forename: Denise M
authors.initials: DM
authors.lastname: Arrick
authors.forename: Wanfen
authors.initials: W
authors.lastname: Xiong
authors.forename: Hong
authors.initials: H
authors.lastname: Sun
mesh_terms: D000098:Acetophenones / Q000494:pharmacology; D000818:Animals; D015153:Blotting, Western; D002545:Brain Ischemia / Q000201:enzymology* / Q000473:pathology*; D002492:Central Nervous System Depressants / Q000633:toxicity*; D000431:Ethanol / Q000633:toxicity*; D007150:Immunohistochemistry; D020244:Infarction, Middle Cerebral Artery / Q000235:genetics / Q000473:pathology; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases / Q000235:genetics / Q000378:metabolism*; D009422:Nervous System Diseases / Q000139:chemically induced / Q000209:etiology / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000473:pathology; D013481:Superoxides / Q000378:metabolism
chemical_list: D000098:Acetophenones; D002492:Central Nervous System Depressants; D008562:Membrane Glycoproteins; D013481:Superoxides; D000431:Ethanol; C056165:acetovanillone; C500593:Cybb protein, rat; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases